Larvol Delta - Elevation-Oncology-Receives-Fast-Track-Designation-from-the-FDA-for-EO3021-for-the-Treatment-of-Adult-Patients-with-Advanced-or-Metastatic-Gastric-or-Gastroesophageal-Junction-Cancer-Expressing-Claudin-182

EO-3021 - Elevation Oncology

https://www.prnewswire.com/news-releases/elevation-oncology-receives-fast-track-designation-from-the-fda-for-eo-3021-for-the-treatment-of-adult-patients-with-advanced-or-metastatic-gastric-or-gastroesophageal-junction-cancer-expressing-claudin-18-2--302254970.html

Sep 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next